Pancreatic Neoplasms Clinical Trials in Shanghai, Shanghai Municipality
6 recruitingShanghai, Shanghai Municipality, China
Showing 1–6 of 6 trials
Recruiting
Phase 2
Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases
Pancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital50 enrolled1 locationNCT07504471
Recruiting
Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
Pancreatic Neuroendocrine TumorSolid Pancreatic Neoplasms
Fudan University1,000 enrolled2 locationsNCT05847855
Recruiting
Phase 2
Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
Pancreatic Neoplasms
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.80 enrolled7 locationsNCT06767813
Recruiting
Phase 2
Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer
Pancreatic Neoplasms
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine30 enrolled1 locationNCT06532617
Recruiting
Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
Pancreatic NeoplasmsDNA MethylationProteome
Zhaoshen Li100 enrolled1 locationNCT05737953
Recruiting
Phase 2
Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer
Neoplasm MetastasisPancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital40 enrolled1 locationNCT06538623